Aromatase inhibitors and their future role in post-menopausal women with early breast cancer.
about
TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer.Aromatase and aromatase inhibitors.The therapeutic potential of novel aromatase inhibitors in breast cancer.Aromatase inhibitors and other novel agents in breast cancer treatment.Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.
P2860
Aromatase inhibitors and their future role in post-menopausal women with early breast cancer.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Aromatase inhibitors and their ...... omen with early breast cancer.
@ast
Aromatase inhibitors and their ...... omen with early breast cancer.
@en
type
label
Aromatase inhibitors and their ...... omen with early breast cancer.
@ast
Aromatase inhibitors and their ...... omen with early breast cancer.
@en
prefLabel
Aromatase inhibitors and their ...... omen with early breast cancer.
@ast
Aromatase inhibitors and their ...... omen with early breast cancer.
@en
P2860
P356
P1476
Aromatase inhibitors and their ...... omen with early breast cancer.
@en
P2860
P2888
P356
10.1038/BJC.1998.756
P407
P478
78 Suppl 4
P577
1998-09-01T00:00:00Z
P5875
P6179
1029665154